Forest Laboratories (FRX) Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder
Go back to Forest Laboratories (FRX) Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder| Forest Laboratories (NYSE: FRX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $100.88 | |||
| Open | $24.87 | 52 Week Low | $64.33 | |||
| Day High | $12.00 | P/E | 20.69 | |||
| Day Low | $12.00 | EPS | $0.58 | |||
| Volume | 20 | |||||
